Literature DB >> 27649643

Disseminated peritoneal leiomyomatosis postmorcellated resection of uterine leiomyomatous tissue.

Miroslav Sekulic1, Laura Moench1, Saeid Movahedi-Lankarani1,2.   

Abstract

In a retrospective review, we identified six cases of disseminated peritoneal leiomyomatosis (DPL) that occurred after resection for uterine leiomyoma(ta) using a morcellation procedure between 2010 and 2016. DPL occurred in less than 1% of all patients who underwent a prior hysterectomy with morcellation, and DPL never occurred without having underwent such a resection. The median age of women at the time of their original resection of uterine tissue was 38.6 years; the median time interval until resection of DPL after the primary morcellation procedure was 73 months and the median age was 48 years. At the time of DPL resection, a median of 6.5 individual lesions was present per patient, with each lesion having a median size of 1.2 cm in the greatest dimension. The most common peritoneal sites of involvement included the sigmoid colon serosa, right pelvis/pelvic side wall, and anterior abdominal parietal peritoneum. The same parameters are described for previously reported cases of DPL in the literature developing after a morcellated resection of uterine leiomyoma(ta). The use of morcellating hysterectomy specimens with leiomyomata may lead to the development of DPL by seeding, may involve numerous peritoneal sites, and often presents 2 years after the original resection.
© 2016 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Disseminated peritoneal leiomyomatosis; morcellator; smooth muscle neoplasm; uterine leiomyoma

Mesh:

Year:  2016        PMID: 27649643     DOI: 10.1111/apm.12601

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  1 in total

1.  Disseminated peritoneal leiomyomatosis: an unusual presentation of intra-abdominal lesion mimicking disseminated malignancy.

Authors:  Sweta Soni; Puneet Pareek; Satya Narayan
Journal:  Med Pharm Rep       Date:  2020-01-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.